다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

GRI

GRI Bio (GRI)

GRI Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:GRI

일자	시간	출처	헤드라인	심볼	기업
2024/05/22	22:15	GlobeNewswire Inc.	GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) Programs	NASDAQ:GRI	GRI Bio Inc
2024/05/21	21:35	GlobeNewswire Inc.	GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)	NASDAQ:GRI	GRI Bio Inc
2024/05/20	21:45	GlobeNewswire Inc.	GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)	NASDAQ:GRI	GRI Bio Inc
2024/05/14	22:05	GlobeNewswire Inc.	GRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company Showcase	NASDAQ:GRI	GRI Bio Inc
2024/05/13	21:00	GlobeNewswire Inc.	GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:GRI	GRI Bio Inc
2024/04/29	21:45	GlobeNewswire Inc.	GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity	NASDAQ:GRI	GRI Bio Inc
2024/04/25	22:15	GlobeNewswire Inc.	GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar	NASDAQ:GRI	GRI Bio Inc
2024/04/16	21:35	GlobeNewswire Inc.	GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent	NASDAQ:GRI	GRI Bio Inc
2024/04/08	21:35	GlobeNewswire Inc.	GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference	NASDAQ:GRI	GRI Bio Inc
2024/04/01	20:35	GlobeNewswire Inc.	GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:GRI	GRI Bio Inc
2024/03/28	22:00	GlobeNewswire Inc.	GRI Bio to Present at the MedInvest Biotech & Pharma Investor Conference	NASDAQ:GRI	GRI Bio Inc
2024/03/14	21:45	GlobeNewswire Inc.	GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators	NASDAQ:GRI	GRI Bio Inc
2024/03/04	22:30	GlobeNewswire Inc.	GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom	NASDAQ:GRI	GRI Bio Inc
2024/02/02	22:00	GlobeNewswire Inc.	GRI Bio Announces Pricing of $5.5 Million Public Offering	NASDAQ:GRI	GRI Bio Inc
2024/01/26	22:05	GlobeNewswire Inc.	GRI Bio Announces Reverse Stock Split	NASDAQ:GRI	GRI Bio Inc
2023/12/05	23:05	GlobeNewswire Inc.	GRI Bio Commences Patient Enrollment in Phase 2a Biomarker Study Evaluating Lead Program GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)	NASDAQ:GRI	GRI Bio Inc
2023/11/27	22:35	GlobeNewswire Inc.	GRI Bio (NASDAQ: GRI) Announces FDA Clearance of IND for Lead Program GRI-0621, a Type 1 Invariant NKT (“iNKT”) Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)	NASDAQ:GRI	GRI Bio Inc
2023/11/15	22:05	GlobeNewswire Inc.	GRI Bio (NASDAQ: GRI) Reports Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:GRI	GRI Bio Inc
2023/10/31	21:45	GlobeNewswire Inc.	GRI Bio Presents Data Supporting Innovative Pipeline of NKT Cell Modulators for the Treatment of High-Value Inflammatory, Fibrotic and Autoimmune Diseases	NASDAQ:GRI	GRI Bio Inc
2023/10/19	21:45	GlobeNewswire Inc.	GRI Bio Presents Translational Data Demonstrating Connection Between NKT Cells and the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) at the 2023 Pittsburgh-Ireland International Lung Conference	NASDAQ:GRI	GRI Bio Inc
2023/10/17	21:35	GlobeNewswire Inc.	GRI Bio Announces Partnership with the Respiratory Translational Research Collaboration to Advance Leading NKT Regulation Technology Targeting Earlier in the Inflammatory Cascade to Modulate Disease Progression	NASDAQ:GRI	GRI Bio Inc
2023/10/11	22:05	GlobeNewswire Inc.	GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO Conference	NASDAQ:GRI	GRI Bio Inc
2023/10/05	21:45	GlobeNewswire Inc.	GRI Bio Announces Publication of Comprehensive Invariant NKT (iNKT) Cell Review in Frontiers in Immunology Demonstrating a Key Role of Type 1 iNKT Cells in Modulating Various Fibrotic Conditions	NASDAQ:GRI	GRI Bio Inc
2023/09/06	22:05	GlobeNewswire Inc.	GRI Bio to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:GRI	GRI Bio Inc
2023/08/23	22:00	GlobeNewswire Inc.	GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIR	NASDAQ:GRI	GRI Bio Inc
2023/08/14	21:05	GlobeNewswire Inc.	GRI Bio (NASDAQ: GRI) Reports Second Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:GRI	GRI Bio Inc
2023/08/07	21:35	GlobeNewswire Inc.	GRI Bio Presents Encouraging Preclinical Data Indicating Oral Administration of GRI-0803 Inhibited Lupus Nephritis and Significantly Improved Overall Survival in Animal Models	NASDAQ:GRI	GRI Bio Inc
2023/08/03	21:30	GlobeNewswire Inc.	GRI Bio (NASDAQ: GRI) to Present at Benzinga’s Virtual Biotech Conference	NASDAQ:GRI	GRI Bio Inc
2023/07/24	22:00	GlobeNewswire Inc.	GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor – The GRI Opportunity Spotlight Event	NASDAQ:GRI	GRI Bio Inc
2023/07/05	21:45	GlobeNewswire Inc.	GRI Bio, Inc. (NASDAQ: GRI) to Participate in the Virtual Investor Summer Spotlight Series	NASDAQ:GRI	GRI Bio Inc

검색 관련기사 보기:NASDAQ:GRI

US Dollar vs Sterling

US Dollar vs Euro

BNP Paribas (QX)

Energy Select Sector SPDR

Verizon Communications

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관